TRILOSTANE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for trilostane and what is the scope of freedom to operate?
Trilostane
is the generic ingredient in one branded drug marketed by Bioenvision and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for trilostane.
Summary for TRILOSTANE
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 92 |
Clinical Trials: | 2 |
Patent Applications: | 7,621 |
DailyMed Link: | TRILOSTANE at DailyMed |
Recent Clinical Trials for TRILOSTANE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The University of Hong Kong | Phase 2 |
Karolinska Institutet | Phase 2 |
Kristina Gemzell Danielsson | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for TRILOSTANE
US Patents and Regulatory Information for TRILOSTANE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioenvision | MODRASTANE | trilostane | CAPSULE;ORAL | 018719-001 | Dec 31, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bioenvision | MODRASTANE | trilostane | CAPSULE;ORAL | 018719-002 | Dec 31, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |